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Abstract 
Prions, the putative causative agents of transmissible spongiform encephalopathies, are neurotropic 
pathogens that spread to the central nervous system via synaptically linked neural conduits upon 
peripheral infection. Axons and their transport processes have been suggested as mediators of nerve-
associated prion dissemination. However, the exact cellular components and molecular mechanisms 
underlying neural spread are unknown. This study used an established hamster scrapie model to 
pursue a novel experimental approach using nerve conduits containing segments devoid of neurites 
generated by incomplete nerve regeneration following Wallerian degeneration to probe the necessity 
of axons for the neural propagation of prions. For this purpose, animals were subjected to unilateral 
sciatic neurectomy 4 weeks before footpad inoculation with scrapie agent. The results showed that the 
regional nerve is the prime conduit for cerebral neuroinvasion and revealed, as evidenced by the 
accumulation of pathological prion protein PrP
TSE
, that prions can proceed along segments of 
peripheral neural projections without detectable axonal structures.  
 
Introduction 
Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases of the 
central nervous system (CNS) in animals and humans, and include scrapie, bovine spongiform 
encephalopathy (BSE), chronic wasting disease (CWD), and Creutzfeldt–Jakob disease (CJD) and its 
variant form, vCJD. The pathognomonic feature of TSEs is the deposition in the CNS of an aberrant 
form of the prion protein (PrP) with a pathologically altered folding and/or aggregation structure. 
Disease-associated forms of the prion protein, here collectively referred to as PrP
TSE
 (Brown & 
Cervenakova, 2005; Beekes & McBride, 2007), can be detected in affected animals and humans by 
analytical methods such as Western blotting (Beekes et al., 1996; Wadsworth et al., 2001), 
immunohistochemistry (McBride et al., 2001; Ironside et al., 2002) and paraffin-embedded tissue 
(PET) blotting (Schulz-Schaeffer et al., 2000), and have been established in many studies as a reliable 
biochemical marker for infectious TSE agents or ‘prions’ (McKinley et al., 1983; Gabizon et al., 1987; 
Bolton et al., 1991; Jendroska et al., 1991; Rubenstein et al., 1991; Beekes et al., 1996; Baldauf et al., 
1997). The prion hypothesis holds that the causative agents of TSEs are proteinaceous infectious 
particles (prions) that consist essentially – if not entirely – of abnormal protease-resistant prion protein 
(Prusiner, 1991).  
During the past few years, comprehensive research on the pathogenesis of peripherally acquired TSE 
infections has achieved substantial progress in dissecting the pathways by which prions spread 
through the body. These studies imply that prions spread from peripheral sites of infection along 
synaptically linked neural conduits to target areas in the brain and spinal cord (Beekes et al., 1998; 
Groschup et al., 1999; McBride et al., 2001; Bartz et al., 2002; Beekes & McBride, 2007). Although 
such defined dissemination along neuroanatomical projections is suggestive of axons as a track for 
prions, hard data on the cellular components and molecular mechanisms that mediate the spread of 
TSE agents in the nervous system are scant. Several studies found that propagation of infection in 
various components of the nervous system takes place at a net rate of 0.7–2 mm day
−1
, which would 
be consistent with transport by slow axonal flow (Kimberlin et al. 1983; Glatzel & Aguzzi, 2000a). 
PrP
TSE
 deposits have been detected in nerve fibres of parenterally infected scrapie hamsters between 
the myelin sheath and axon (Groschup et al., 1999) and described to be present within axons in brain 
samples from CJD patients (Kovacs et al., 2005). However, transgenic mice overexpressing four-
repeat tau with a reported impairment of axonal transport displayed comparable incubation times to 
control mice following intraneural infection with scrapie (Künzi et al., 2002). Also, the incubation time 
after peripheral prion infection was not found to be altered in mice with a heterozygous mutation of 
  
dynein, a motor protein involved in the transport of axonal cargo along the cytoskeleton (Hafezparast 
et al., 2005). In addition, pharmacological segregation of axonal neurofilaments and microtubuli by 
β,β′-iminodiproprionitrile did not influence the observed rate of spread of infection along peripheral 
nerves after administration of scrapie agent into the footpad of hamsters (Kratzel et al., 2007a). Thus, 
apparently conflicting findings argue in favour or against axons and their transport mechanisms as key 
mediators of nerve-associated prion dissemination. In contrast, the axonal movement of cellular PrP 
has been well established (Borchelt et al., 1994; Butowt et al., 2006).  
Here, we used sciatic neurectomy as an experimental tool to generate in vivo incomplete nerve 
conduits containing segments depleted or devoid of axons, allowing further scrutinization of the host 
components necessary for the propagation of prions along neural pathways. Surprisingly, examination 
of the model conduits produced by our approach revealed that prion propagation seems to be possible 
along nerve structures that do not contain detectable axonal components.  
 
Methods 
Manipulations of neural structures in animals. 
The animal experiments complied with German legal regulations and were approved by the 
responsible authorities. For neurectomy, animals were anaesthetized with a ketamine/xylazine mixture 
[100 and 5 mg (kg body weight)
−1
, respectively]. After shaving and skin disinfection, the right distal 
sciatic nerve was excavated at the femoral level by surgical dislocation of the biceps femoris muscle. 
The nerve was gently swabbed with 2 % lidocaine. Dissection was performed using a thermo-
coagulator and a nerve segment of about 3 mm was removed. The anatomical structures were 
repositioned and the skin was closed with a Vicryl 5.0 suture.  
Mock-operated control animals were anaesthetized and skin suture was carried out at the femoral 
level on the right hind leg. 
 
Animal inoculation. 
Adult male and female Syrian hamsters were sedated with isoflurane and infected with scrapie by 
inoculation into the footpad. For infection with two different concentrations of prions, 20 μl of a 0.001 % 
(w/v, ‘low dose’) or 2 % (w/v, ‘high dose’) scrapie 263K strain hamster brain homogenate from 
terminally ill donor animals were injected into the sole of the right foot using a 27-gauge cannula. The 
animals were regularly monitored for clinical signs of scrapie (Kratzel et al., 2007a). When terminally 
affected with scrapie, or when the experiment was terminated at 314 days post-infection (p.i.), the 
hamsters were sacrificed by CO2 asphyxiation.  
 
Experimental groups and tissue collection. 
Footpad infections with low or high doses of scrapie agent were performed at 4 weeks after mock 
operation (n=7 for each of the low- and high-dose groups) or neurectomy (n=8 for each of the low- and 
high-dose groups). Non-neurectomized negative-control animals (n=4) were similarly mock infected 
with a 2 % (w/v) normal hamster brain homogenate. One animal in the mock-operated high-dose group 
died before termination of the experiment for reasons unrelated to TSE disease. For PET blot 
detection of cerebral PrP
TSE
, brains were removed from animals, and for immunohistological 
examinations of axonal cytoskeleton components (i.e. tubulin and neurofilaments), sciatic nerve 
samples were obtained from two neurectomized hamsters that succumbed to terminal scrapie at 155 
days after infection with a high dose of scrapie agent. These nerve specimens, and the brains for PET 
blotting, were fixed overnight immediately after collection by immersion in 4  % (v/v) formaldehyde. After 
incubation in PBS (pH 7.2), tissue samples were transferred to 70  % ethanol, processed in a tissue 
processor and subsequently embedded in paraffin wax. Nerve specimens from four neurectomized 
animals that developed terminal scrapie after footpad infection with a high dose of scrapie agent were 
collected for Western blot testing for PrP
TSE
. These specimens were frozen at −80 °C immediately 
after preparation. For the Western blots, sciatic nerve specimens were further dissected into proximal 
  




Tissue extraction of PrP
TSE
 in the form of protease-resistant PrP27–30 was initiated by collagenase 
digestion of samples for 1 h and subsequently performed as described previously (Thomzig et al., 
2003). The extracts were subjected to PAGE and Western blotting using the anti-PrP monoclonal 
antibody (mAb) 3F4 (Kascsak et al., 1987) as described in detail elsewhere (Thomzig et al., 2003). 
Samples from uninfected hamsters spiked with 263K scrapie brain homogenate from terminally ill 
donors were used as positive controls for the extraction procedure, as specified in the legend to Fig. 
5⇓.  
 
Immunohistochemistry and PET blotting. 
For post-mortem microscopic examination of the status of unmanipulated and dissected nerves, cross-
sections of sciatic tissue samples were immunohistochemically stained using mAbs for neurofilaments 
(2F11; DakoCytomation) and tubulin (Abcam) diluted 1  : 50 and 1 : 200 in PBS, respectively. 
Fluorescent-labelled secondary antibodies (Oregon Green and Texas Red, as appropriate) were 
diluted 1 : 100.  
PET blotting of brain sections was performed according to the method of Schulz-Schaeffer et al. 
(2000) with slight modifications. In brief, 6 μm thick sections were dried on nitrocellulose membranes 
overnight at 55 °C. After deparaffinization, sections were digested overnight with 15 μg proteinase K 
ml
−1
 in digestion buffer containing 10 mM Tris/HCl (pH 7.8), 30 mM NaCl and 0.1 % (w/v) Brij-35 
detergent. Sections were denatured in 3 M guanidine thiocyanate and blocked with 0.2 % (w/v) casein 
before labelling with the primary mAb 3F4 diluted 1  : 2500. Binding of the secondary antibody diluted 
1 : 2000 was visualized using NBT/BCIP (AppliChem).  
 
Results 
Prion dissemination to the brain and development of clinical disease 
Neurectomy and mock operation were well tolerated by all animals. As expected, immediately after 
neurectomy, hamsters showed a complete loss of motor function and sensation distal to the tarsus. 
Footpad infection with scrapie agent was performed at 4 weeks after the neurectomy in order to avoid 
residual inflammatory processes possibly interfering with scrapie pathogenesis (Heikenwälder et al., 
2005; Kratzel et al., 2007b) and to ensure axonal degeneration distal to the transection side.  
After footpad infection of hamsters with the low dose of scrapie agent, six out of seven mock-operated 
animals developed clinical signs of scrapie and reached the terminal stage of disease between 219 
and 308 days p.i. (Fig. 1a⇓). Spot-checked animals from this group including the non-diseased 
hamster (n=5) showed PrP
TSE
 accumulation in the brain as evidenced by PET blotting (Fig. 2a⇓). In 
contrast, none of the eight neurectomized animals developed clinical signs of scrapie after the low-
dose challenge up to termination of the experiment at 314 days p.i. (Fig. 1a⇓). Only one of these 
animals showed the start of cerebral PrP
TSE
 deposition, whereas the other seven animals produced 
negative results following PET blotting for PrP
TSE
 (Fig. 2b⇓).  
All animals, whether neurectomized or mock-operated controls, subjected to a high-dose scrapie 
infection via the footpad developed disease-specific terminal symptoms of scrapie and displayed 
widespread accumulation of PrP
TSE
 in cerebral PET blots (not shown). The incubation time for mock-
operated control animals was 112±3 days p.i. (mean±sd) compared with 182±9 days p.i, for 
neurectomized animals (P < 0.0001, two-tailed unpaired Student's t-test, Fig. 1b⇑).  
Hamsters mock-challenged with normal brain homogenate remained free of scrapie symptoms until 
termination of the experiment. 
  
Status of nerve regeneration 
Post-mortem macroscopic examination of sciatic nerves from all neurectomized animals revealed the 
process of nerve regeneration. Nerve-like tubes between proximal and distal nerve stumps could be 
observed and proximal stumps often showed a neuroma-like formation (Fig. 3⇓).  
Cross-sections of nerve specimens from two animals inoculated with a high dose of scrapie agent 
were examined immunohistochemically in more detail with particular attention on the axonal 
regeneration status after having succumbed to terminal scrapie at 155 days p.i. (Fig. 4a–h⇓). Control 
nerve segments from the unmanipulated contralateral side of these animals showed regular 
immunofluorescent staining of axonal key components such as tubulin and neurofilaments (Fig. 4a 
and e⇓). Staining of nerve segments from the neurectomized ipsilateral side revealed strong but 
disordered signals for tubulin and neurofilament in the proximal nerve stumps (Fig. 4b and f⇓), weak 
signals in the medial nerve tubes (Fig. 4c and g⇓) and no signals for the tested axonal components in 
the distal stump (Fig. 4d and h⇓).  
 
Western blot detection of PrP
TSE
 in regenerated nerve conduits  
Nerve specimens from four neurectomized animals that developed terminal scrapie after footpad 
infection with a high dose of scrapie agent were tested by Western blotting for PrP
TSE
. The 
biochemical marker of prion infectivity could be detected in the proximal stumps, in the medial portions 
and in the distal stumps of the regenerating sciatic nerves (Fig. 5⇓).  
 
Discussion 
A variety of studies have shown that peripheral prion infections proceed to the CNS along neural 
conduits (Fraser, 1982; Beekes et al., 1998; Groschup et al., 1999; McBride et al., 2001; Bartz et al., 
2002; Beekes & McBride, 2007). This, and other findings, has led to the suggestion that axons are 
essentially involved in the neural spread of prions and, more specifically, that axonal transport 
mechanisms may mediate this process. However, several experimental approaches have produced 
apparently contradictory results on the role of axons (Künzi et al., 2002; Hafezparast et al., 2005; 
Kovacs et al., 2005; Kratzel et al., 2007a), and other modes of spread of prions along neural 
projections are conceivable. Among these might be cell-free or cell-associated dissemination in 
perineural lymphatics as well as in neural interspaces (Mims & White, 1984) or sequential infection of 
Schwann cells (Follet et al., 2002). Alternatively, exosomal vehicles for transmission of the infectious 
prion protein (Février et al., 2005) or internalization of secreted forms of PrP by neighbouring cells 
(Butowt et al., 2006) have been discussed, and Glatzel & Aguzzi (2000b) suggested a domino-like 
conversion of cellular PrP into PrP
TSE
.  
In order to establish whether prion propagation in peripheral neural tissue is feasible without an intact 
axonal anatomy or any detectable axonal structures at all, we used a functional sciatic nerve model, 
which constituted a neural conduit containing segments depleted or devoid of axons. Neurectomy of 
regional nerves was carried out previously for studies on the pathogenesis of neurotropic infectious 
diseases (Bassant et al., 1986; Carbone et al., 1987). However, to the best of our knowledge, nerve 
segments devoid of axons purposefully induced by experimental surgery have not been used to date 
to probe the necessity of neurites in the spread of prions through the body.  
Sciatic neurectomy as performed in our hamster model is known to induce Wallerian degeneration in 
the distal nerve stumps (Waller, 1850; Burnett & Zager, 2004). After a latency period of a few days, 
physical fragmentation of both axons and myelin occurs in the disconnected distal stump. Axon and 
myelin debris are phagocytosed by Schwann cells and macrophages. Finally, only nerve fibre 
remnants consisting of Schwann cells within an endoneurial sheet remain in the distal stump. This 
degenerative process is usually completed within a few weeks. Nerve regeneration may be initiated by 
Schwann cell proliferation starting from the proximal stump, leading to continuous columns of cells 
known as the bands of Büngner (Büngner, 1891). These bands provide a guide for axons that can 
sprout from the proximal stump into surrounding tissue and eventually grow into the distal stump (Ide, 
1996; Burnett & Zager, 2004). However, after transection, such regenerating axons are no longer 
guided by their original sheaths and are thus likely to fail functionally correct reinnervation.  
  
In our study, the effect of sciatic neurectomy observed upon footpad infection of hamsters with a low 
dose of scrapie agent was pronounced (Fig. 1a⇑). Six out of seven mock-operated hamsters 
developed terminal scrapie between 219 and 308 days p.i. In contrast, all neurectomized animals 
remained free of symptoms until 314 days p.i. when the experiment for this group was terminated, and 
only one of these animals showed weak deposition of PrP
TSE
 in the brain. These effects of neurectomy 
functionally demonstrated that the nerve innervating the site of infection provided the prime conduit for 
prions to the CNS after footpad inoculation. For hamsters subjected to neurectomy of the sciatic nerve 
before high-dose scrapie footpad infection, we observed a prolongation of the survival time of about 
60 % compared with mock-operated control animals (Fig. 1b⇑). The difference between the observed 
incubation times without and with neurectomy (112 vs 182 days) approximately corresponded to that 
observed in incubation time-interval assays after intracerebral inoculation of 1.5×10
2
 LD50 and a 100-
fold lower dose, respectively (not shown).  
However, despite substantially prolonged survival after sciatic neurectomy, all animals of the high-
dose group succumbed to terminal disease. How did the infection spread to the CNS in these 
animals? Centripetal spreading pathways via non-sciatic neural projections, lymph or blood may 
provide an explanation. However, excision of the draining lymph node 4 weeks before footpad 
inoculation of non-neurectomized hamsters with 2 % 263K scrapie brain homogenate did not alter 
survival time (Kratzel et al., 2007b). Alternatively, delayed invasion of the brain could be accounted for 
by prion propagation from the distal nerve stump after partial sciatic regeneration. This prompted us to 
examine the disrupted parts of the sciatic nerve in more detail. An inspection of the operation site 
revealed that all neurectomized hamsters developed macroscopically visible tube-like structures 
connecting the proximal and distal stumps of the transected nerves (Fig. 3⇑), although functional 
recovery was not observed in any of the neurectomized animals. Immunohistochemical examination 
with antibodies specific to key components of the axonal cytoskeleton such as tubulin and 
neurofilaments indicated sprouting axons in the proximal neuroma, growing distally to the level of the 
former nerve transection (Fig. 4b–d and f–h⇑). No evidence of axons could be detected in the 
examined distal stumps of terminally ill hamsters from the high-dose group sacrificed at 155 days p.i. 
(Fig. 4d and h⇑). In contrast, when we tested regenerated nerve samples from scrapie hamsters 
between 150 and 212 days p.i. for PrP
TSE
 by highly sensitive Western blotting (Fig. 5⇑), PrP
TSE
 was 
consistently found in the proximal and medial portion of the injured nerve, and also in the distal nerve 
stumps.  
The footpad inoculations of scrapie agents were performed 4 weeks after the neurectomy when 
Wallerian degeneration in the distal nerve stump was fairly advanced, and previous studies have 
shown that, even in intact sciatic nerves, PrP
TSE
 becomes detectable only at 60 days following footpad 
infection (Kratzel et al., 2007a). Thus, the accumulation of PrP
TSE
 in the distal nerve stumps cannot 
represent a remnant from prion propagation in the distal nerve stumps occurring prior to Wallerian 
degeneration, but must have been sustained by neural components other than axons.  
Schwann cells have been shown to express cellular PrP in murine nerves and displayed PrP
TSE
 
formation after exposure to scrapie agent in culture (Follet et al., 2002). Furthermore, Herzog et al. 
(2004) reported the detection of PrP
TSE
 in Schwann cells of the sciatic nerve from primates 
peripherally infected with BSE agent. In the peripheral nervous system (PNS), these glial cells 
ensheath axonal projections as well as synaptic junctions (Fields & Stevens-Graham, 2002). Against 
this background, the prion propagation we observed in axon-free neural repair tissue of distal nerve 
stumps can plausibly be explained by an involvement of Schwann cells. However, other modes of non-
axonal spread cannot be ruled out as yet and also need to be addressed in future studies. 
Additionally, it must be emphasized that our findings do not necessarily argue against a key role for 
axonal conduits for the spread of prions along neural projections. Rather, they hint at an alternative or 
additional mode of propagation that may operate in parts of the PNS and possibly involves Schwann 
cells. Evidently, the role of glial cells and other non-neuronal components in the spread of TSE agents 
along PNS projections requires further elucidation – for example, by studies using transgenic mice, by 
pharmacological approaches or by using the model system of neural conduits devoid of axons 
described in this report.  
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Tables and Figures 
 
 
Figure 1. Effect of sciatic neurectomy on the survival of hamsters infected via the footpad with a low 
dose (a; 0.001 %) or high dose (b; 2 %) of 263K scrapie brain homogenate compared with mock-




Figure 2. Representative results of PET blot testing for PrP
TSE
 in coronal brain sections from hamsters 
infected via the footpad with a low dose (0.001  %) of 263K scrapie brain homogenate. (a) Specimen 
from a mock-operated hamster that succumbed to terminal disease at 299 days p.i., showing 
substantial immunolabelling for PrP
TSE
. (b) Specimen from a neurectomized animal showing no clinical 
signs of scrapie or detectable cerebral deposition of PrP
TSE









Figure 3.  Representative appearance of sciatic nerve specimens excised at the site of neurectomy 
(arrow, right specimen) and the corresponding contralateral region (left specimen) from hamsters that 
developed terminal scrapie upon footpad infection with a high dose (2  %) of 263K scrapie brain 
homogenate. The asterisk indicates the proximal, neuroma-like stump and the diamond indicates the 







Figure 4. Photomicrographs of sciatic cross-sections representing the region of neurectomy and an 
unmanipulated contralateral nerve segment of a hamster that succumbed to terminal scrapie at 155 
days p.i. following footpad infection with a high dose (2  %) of 263K scrapie brain homogenate. 
Immunofluorescent labelling of tubulin (red, a–d) and neurofilaments (green, e–h) in sciatic nerve 
segments from the unmanipulated contralateral side (a, e) and the manipulated ipsilateral side (b–d, f–
h). Proximal samples (b and f) show strong disordered signals for tubulin and neurofilaments. Weak 
signals for tubulin and neurofilaments were found in the nerve-like tubes between the proximal and 
distal nerve stumps (c and g). No signals for the tested axon components were detected in the distal 





















Figure 5.  Representative Western blots for the detection of PrP27–30, the protease-resistant core of 
PrP
TSE
, in ipsilateral sciatic nerve specimens from three hamsters that were infected in the footpad 
with a high dose (2 %) of 263K scrapie brain homogenate after neurectomy. Due to the small and 
varying sample sizes of proximal and distal nerve stumps (range 1.4–3.6 mg) and of medial nerve 
tubes (range 0.6–0.9 mg), a precise standardization of sample loading was not possible. Thus, the 
Western blot signals provide a qualitative indicator for the presence of PrP
TSE
 but cannot be directly 
compared quantitatively. (a) Molecular mass marker (27 kDa); (b) blot control sample containing 10
−6
 g 
263K scrapie brain tissue; (c, f and i) proximal nerve stumps; (d, g and j) medial nerve tubes, located 
between the proximal and distal nerve stumps; (e, h and k) distal nerve stumps; (l) processing control, 
spiked with 10
−5
 g 263K scrapie brain tissue prior to extraction of PrP
TSE
. Sciatic samples from animals 
inoculated into the footpad with normal hamster brain homogenate did not produce any Western blot 
signals (not shown).  
 
 
 
